EXPRESSION OF COMPLEMENT COMPONENTS OF THE ALTERNATIVE PATHWAY BY GLIOMA CELL-LINES

被引:0
|
作者
GASQUE, P [1 ]
JULEN, N [1 ]
ISCHENKO, AM [1 ]
PICOT, C [1 ]
MAUGER, C [1 ]
CHAUZY, C [1 ]
RIPOCHE, J [1 ]
FONTAINE, M [1 ]
机构
[1] CTR HENRI BECQUEREL,IMMUNOCHEM LAB,F-76038 ROUEN,FRANCE
来源
JOURNAL OF IMMUNOLOGY | 1992年 / 149卷 / 04期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Glioma cell lines express proteins of the complement alternative pathway, namely C3, factor B, factor H, and factor 1. Secretion of these proteins was shown by a sensitive and specific ELISA. C3 and factor H were rapidly secreted by glioma cell line CB193 and reached a concentration of 140 ng/ml/10(6) cells after 72 h of culture. Factor B and factor I were secreted at a lower rate and reached concentrations of 25 and 15 ng/ml/10(6) cells, respectively. Western blot and immunoprecipitation experiments showed that secreted proteins were identical to the corresponding plasma proteins. For factor H, besides the well known 150-kDa species, an additional polypeptide of 45 kDa with factor H immunoreactivity was observed. This species corresponded to the N-terminal truncated form found in plasma. In preliminary experiments, we observed control of these syntheses by cytokines. IL-1-beta significantly increased C3 secretion, with no effect on factor H. Secretion of factor H was enhanced by IFN-gamma. These results show that a glioma cell line could be a useful tool to study complement biosynthesis by glial cells in humans.
引用
收藏
页码:1381 / 1387
页数:7
相关论文
共 50 条
  • [1] COMPLEMENT EXPRESSION IN HUMAN BRAIN - BIOSYNTHESIS OF TERMINAL PATHWAY COMPONENTS AND REGULATORS IN HUMAN GLIAL-CELLS AND CELL-LINES
    GASQUE, P
    FONTAINE, M
    MORGAN, BP
    JOURNAL OF IMMUNOLOGY, 1995, 154 (09): : 4726 - 4733
  • [2] EXPRESSION OF TRANSCRIPTS OF COMPLEMENT COMPONENTS AND THEIR RECEPTORS DURING DIFFERENTIATION OF EMBRYONAL CARCINOMA CELL-LINES
    KOHCHI, C
    OSHIMA, H
    MIZUNO, D
    SOMA, GI
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (02) : 863 - 868
  • [3] PROTOONCOGENE EXPRESSION IN HUMAN GLIOMA DERIVED CELL-LINES
    HAMEL, W
    WESTPHAL, M
    SHEPARD, HM
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1992, 1 (06) : 673 - 682
  • [4] CYTOKINE GENE-EXPRESSION ON GLIOMA CELL-LINES AND SPECIMENS
    YAMANAKA, R
    TANAKA, R
    SAITOH, T
    OKOSHI, S
    JOURNAL OF NEURO-ONCOLOGY, 1994, 21 (03) : 243 - 247
  • [5] EXPRESSION OF P-GLYCOPROTEIN IN HUMAN GLIOMA CELL-LINES AND SURGICAL GLIOMA SPECIMENS
    MATSUMOTO, T
    TANI, E
    KABA, K
    SHINDO, H
    MIYAJI, K
    JOURNAL OF NEUROSURGERY, 1991, 74 (03) : 460 - 466
  • [6] AMPLIFICATION AND EXPRESSION OF A MULTIDRUG RESISTANCE GENE IN HUMAN GLIOMA CELL-LINES
    MATSUMOTO, T
    TANI, E
    KABA, K
    KOCHI, N
    SHINDO, H
    YAMAMOTO, Y
    SAKAMOTO, H
    FURUYAMA, J
    JOURNAL OF NEUROSURGERY, 1990, 72 (01) : 96 - 101
  • [7] TENASCIN EXPRESSION IN HUMAN GLIOMA CELL-LINES AND NORMAL-TISSUES
    VENTIMIGLIA, JB
    WIKSTRAND, CJ
    OSTROWSKI, LE
    BOURDON, MA
    LIGHTNER, VA
    BIGNER, DD
    JOURNAL OF NEUROIMMUNOLOGY, 1992, 36 (01) : 41 - 55
  • [8] PATTERNS OF PROTO-ONCOGENE EXPRESSION IN HUMAN GLIOMA CELL-LINES
    LAROCCA, RV
    WESTERMARK, B
    ISRAEL, MA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 178 - 178
  • [9] ESTABLISHMENT OF HUMAN GLIOMA CELL-LINES WITH STABLE AND UNSTABLE GFAP EXPRESSION
    ONDA, K
    WASHIYAMA, K
    TANAKA, R
    NISHIYAMA, A
    USUI, H
    KUMANISHI, T
    BIOMEDICAL RESEARCH-TOKYO, 1992, 13 (05): : 327 - 334
  • [10] PATTERNS OF PROTO-ONCOGENE EXPRESSION IN HUMAN GLIOMA CELL-LINES
    LAROCCA, RV
    ROSENBLUM, M
    WESTERMARK, B
    ISRAEL, MA
    JOURNAL OF NEUROSCIENCE RESEARCH, 1989, 24 (01) : 97 - 106